In the kidneys, PRMT3 lacks cancer-associated interacting proteins and thus prioritizes binding to ADMA precursor proteins, generating ADMA through methylation and inhibiting NOS activity to mitigate fibrotic damage (18). The gene discussed is PRMT3; the disease is cancer.